Showing results (191-200 of 938) with videos related to
Sort By:
Pageof 94
European Journal of Pharmacology|November 1, 1988
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmosetJ A Temlett, P N Chong, W H Oertel, et al.Biochemical Pharmacology|February 1, 1982
Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivityP Jenner, M D Hall, K Murugaiah, et al.Synapse (New York, N.Y.)|June 1, 1993
Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic studyK K Gnanalingham, L A Smith, A J Hunter, et al.European Journal of Pharmacology|August 25, 1992
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal gangliaM D Taylor, M L De Ceballos, S Rose, et al.British Journal of Pharmacology|August 1, 1988
The interaction of substituted benzamides with brain benzodiazepine binding sites in vitroR W Horton, S Lowther, J Chivers, et al.Neuropharmacology|June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.Brain : a Journal of Neurology|September 1, 1977
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepamD Chadwick, M Hallett, R Harris, et al.Journal of Neural Transmission|January 1, 1987
Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapineN M Rupniak, S A Prestwich, R W Horton, et al.Psychopharmacology|April 2, 1999
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.European Journal of Pharmacology|September 30, 1983
Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivityN Rupniak, M Hong, S Mansfield, et al.Pageof 94